Significance Statement {#s1}
======================

Understanding the synaptic mechanisms of learning and memory is critically to the field of neuroscience and for human health. A key neurotransmitter receptor involved in learning is the NMDA receptor, and exploration of its regulation is vital. Here, we optimized optical tools to allow detailed characterization of NMDA receptor activity at single synapses, along with analysis of synaptic structural features. The amount of receptor activation is independent of synapse size, but weakly dependent on synapse position within the dendritic tree. Notably, we found that NMDA receptors activated following spontaneous neurotransmitter release tend be GluN2B-containing receptors. The unique mechanisms that regulate the number and positioning of these receptors within synapses will have important consequences for control of synaptic development and signaling.

Introduction {#s2}
============

NMDA-type glutamate receptor (NMDAR) activation is critical for learning and memory. This is because of the unique ability of NMDARs to allow influx of Ca^2+^ into dendritic spines following glutamate binding and sufficient membrane depolarization ([@B59]; [@B6]). It is well established that NMDAR activation by action potential (AP)-dependent neurotransmitter release initiates complex signaling within the postsynaptic density (PSD), which underlies many forms for synaptic plasticity and is essential for normal synaptic function ([@B53]; [@B40]; [@B41]; [@B45]; [@B47]). However, NMDAR activation by spontaneous glutamate release, although less studied, also plays a central role in synaptic function. NMDAR-mEPSCs in hippocampus are quite small, ranging from 3 to 20 pA ([@B75]; [@B111]; [@B76]), and they show a high degree of variability in amplitude ([@B10]). Nevertheless, blockade of NMDAR-mEPSCs induces local protein synthesis-dependent synaptic plasticity ([@B99], [@B101]; [@B30]; [@B3]), and NMDAR-mEPSCs mediate synaptic development at distal sites ([@B2]). It has been hypothesized that the amount of Ca^2+^ influx through NMDARs within a synapse may lead to different downstream effects ([@B22]) and therefore is a critical factor in determining how individual synapses function. Thus, understanding how NMDAR activation due to spontaneous release events is regulated at individual synapses is essential for our understanding of how synapses are maintained and modulated.

Though spontaneous transmission clearly utilizes mechanisms that for the most part are in common with AP-evoked transmission, some evidence has accrued to suggest that it involves unique elements both presynaptically and postsynaptically. Application of open channel blockers during evoked release led to an elimination of responses because of evoked but not spontaneous release and vice versa for NMDARs, as well as AMPA receptors. This suggests that receptors activated by spontaneous release may form a synaptic pool separate from receptors activated by evoked release within a single synapse ([@B7]; [@B87]). Additionally, there is some evidence that glutamate vesicles that fuse spontaneously are drawn from a specific subset of the total vesicle pool ([@B86]; [@B32]; [@B77]; [@B1]), though this is still a subject of some debate ([@B74]; [@B37]; [@B46]; [@B112]). However, that spontaneous activation drives signaling pathways through NMDAR activation at individual synapses that are unique from those induced by evoked release ([@B101]; [@B8]), supports the notion that a portion of synaptic NMDARs are specifically activated by spontaneously released glutamate. Together, this highlights the need to understand the factors at individual synapses that control the type and numbers of NMDARs activated by spontaneous release.

One such parameter could be NMDAR subunit composition, which is a major factor that influences both receptor biophysical properties and downstream signaling pathways ([@B72]; [@B92]). NMDARs are typically assembled from two GluN1 subunits and two GluN2 subunits that either are two GluN2A (GluN2A-NMDARs), two GluN2B (GluN2B-NMDARs), or triheteromers with one of each type of GluN2 subunit (GluN2A/B-NMDARs; [@B78]; [@B106]; [@B39]). These receptor types have biophysical differences in glutamate affinity, channel open time, and decay kinetics that lead to differences in Ca^2+^ influx magnitude and kinetics ([@B85]). In addition, they engage in different protein--protein interactions within the PSD to gate unique downstream signaling pathways ([@B72]; [@B92]). Thus, which NMDAR subunits contribute to NMDAR activation by spontaneous release may underlie differences in receptor activation and subsequent functional effects.

For AMPA receptors (AMPARs), there is a strong relationship between the amount of receptor activation and the size of the spine ([@B64]). This suggests that synapse structure may be an additional critical factor in modulating NMDAR activation by spontaneous release. However, neither the number of NMDARs present ([@B55]; [@B104]; [@B90]; [@B20]), nor the amount of NMDAR activation by glutamate uncaging ([@B95]) or evoked release ([@B70]), was correlated with synapse size. Nevertheless, because NMDAR activation due to spontaneous release may diverge from the total synaptic NMDAR pool, we asked whether spontaneous NMDAR activation is sensitive to synaptic spine or synapse size.

Here we combined single-synapse Ca^2+^ imaging with confocal and super-resolution microscopy to explore the relationship between NMDAR activation due to spontaneous single vesicle exocytosis and morphologic features of individual synapses. We find that NMDAR activation by spontaneous release is mediated primarily through GluN2B-NMDARs. The amount of Ca^2+^ influx was not correlated with spine or synapse size, and only weakly correlated with synapse position on the neuron. However, the magnitude of activation was highly variable at individual synapses. Thus, the high degree of variability of spontaneous NMDAR activation is most likely dominated by stochastic channel fluctuations and by nanoscale intrinsic properties of the synapse including receptor position, release site position, and the glutamate concentration profile following each release event.

Materials and Methods {#s3}
=====================

Cell culture and GCaMP6f expression {#s3A}
-----------------------------------

Dissociated hippocampal cultures were prepared from E18 rats of both sex and plated on glass coverslips coated with poly-L-lysine. A subset of cells was infected with pAAV.CAG.GCaMP6f.WPRE.SV40 (Penn Vector Core) at 0 DIV and plated along with uninfected cells so that on each coverslip there is a mix of infected and uninfected cells. This allowed us to vary the ratio of infected cells to uninfected cells plated based on the requirement of the experiment. For most experiments 10,000--15,000 infected cells were plated with 40,000 uninfected cells to have a total density ∼50,000/well. For correlative Ca^2+^ imaging and super-resolution experiments we used 1000 infected cells plated with 30,000 uninfected cells per well. Transfections were performed using Lipofectamine at 18 DIV with either GCaMP6f or tdTomato, and constructs were allowed to express for 3 d, followed by imaging at 21 DIV. All animal procedures were performed in accordance with the University of Maryland Baltimore animal care and use committee's regulations.

Ca^2+^ imaging {#s3B}
--------------

Ca^2+^ imaging was performed on three very similar spinning disk confocal systems. The first was a CSU-22 confocal (Yokagawa) with a Zyla 4.2 sCMOS camera (Andor) mounted on the side port of an Olympus IX-81 inverted microscope, using a 60×/1.42 oil-immersion objective. The second system used the same camera, microscope, and objective as above but the CSU-22 confocal was replaced with a Dragonfly multimodal system (Andor). All time-lapses were acquired at 20 Hz controlled by IQ3 software (Andor). Following time-lapse acquisition, a *z*-stack of the field was acquired using 50--200 ms frames and 0.5 µm steps between planes. Coverslips were imaged in ACSF containing 0 m[m]{.smallcaps} Mg^2+^, 139 m[m]{.smallcaps} NaCl, 2.5 m[m]{.smallcaps} KCl, 1.5 m[m]{.smallcaps} CaCl~2~, 10 m[m]{.smallcaps} glucose, and 10 m[m]{.smallcaps} HEPES, pH adjusted to 7.4 with NaOH, 1 μ[m]{.smallcaps} TTX (Enzo), 10 μ[m]{.smallcaps} DNQX (Sigma-Aldrich), 20 μ[m]{.smallcaps} ryanodine (Tocris Bioscience), 1 μ[m]{.smallcaps} thapsigargin (Sigma-Aldrich), and 5 μ[m]{.smallcaps} nifedipine (Sigma-Aldrich). All experiments were performed using an objective heater to maintain bath temperature near 37°C. To maintain the plane of focus, autofocus was performed every minute using an Olympus ZDC2. For experiments with a treatment (adding blockers, ifenprodil, raising Ca^2+^, and raising Mg^2+^), baseline imaging of 4--6 min was followed by application of either drugs or vehicle (ACSF or DMSO, depending on drug) and then by an additional 4--6 min of imaging. The third spinning disk confocal system was a Nikon W1 equipped with a 40×/1.3 oil-immersion objective and Hamamatsu Flash4.2 camera, mounted on a Ti2 microscope. This was used for imaging the larger dendritic trees in [Figure 4](#F4){ref-type="fig"}, and images were acquired using otherwise the same parameters and conditions as above. For experiments in Extended Data [Figure 2-1](#fig2-1){ref-type="supplementary-material"}, experiments using transfected cells, as well as [d-]{.smallcaps}serine experiments were performed on a Nikon Ti2 equipped for wide-field fluorescence imaging using a 40×/1.3 oil-immersion objective and a Zyla 4.2 sCMOS camera. Autofocus was maintained continuously, and acquisition parameters were otherwise the same as above.

![mSCaTs measured by GCaMP6f imaging reflect NMDAR activation at individual synapses following spontaneous single vesicle release. ***A***, Cultured hippocampal neuron infected with AAV-GCaMP6f. Left, GCaMP6f average (green); middle, ΔF calculated by subtracting GCaMP6f average from GCaMP6f maximum projection (magenta); right, merge of GCaMP6f average (green) and ΔF (magenta). Bottom, Zoom in of boxed spine from cell in top left. First panel is GCaMP6f average, the 2nd through 4th panels are individual frames showing a single mSCaT at 0, 400, and 800 ms, respectively. Red circles indicate ROIs for data traces shown in ***B***. ***B***, ΔF/F traces from spine and dendrite regions circled in red in ***A***. ***C***, Frequency histogram of mSCaT amplitude for individual synapses across 923 spines from 8 cells. ***D***, Frequency histogram of mSCaT frequency for individual synapses across 923 spines from 8 cells. ***E***, Representative GCaMP6f traces demonstrating that treatment with ryanodine, thapsigargin, DNQX, and nifedipine (blockers) did not alter mSCaT amplitude compared with vehicle treatment. ***F***, Quantification of effect of blockers on mSCaT amplitude compared with vehicle treatment revealed that blockade of non-NMDAR sources of Ca^2+^ did not impact mSCaT amplitude. ***G***, Representative GCaMP6f traces demonstrating that treatment with APV eliminated mSCaTs compared with vehicle treatment. ***H***, Treatment with APV eliminates 94% of events. ***I***, Raising extracellular Ca^2+^ causes increased mSCaT amplitude, whereas application of 30 μ[m]{.smallcaps}, 100 μ[m]{.smallcaps}, and 1 m[m]{.smallcaps} Mg^2+^ reduce mSCaT amplitude. For example traces, see Extended Data [Figure 1-1](#fig1-1){ref-type="supplementary-material"}. ns, not significant; \*\*\*\**p* \< 0.0001.](enu0031929450001){#F1}
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Example mSCaT traces from cells in [Figure 1](#F1){ref-type="fig"}. Example mSCaT traces for data from [Figure 1*I*](#F1){ref-type="fig"}. Download Figure 1-1, PDF file.
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Chronic expression of GCaMP6f does not alter GluN2B-NMDAR contribution to mSCaTs or GluN2B developmental shift. ***A***, Ifenprodil has the same effect on mSCaT amplitude for transiently transfected cells as infected cells (Normalized amplitude: Veh-infected: 0.98 ± 0.016, *n* = 1196/20; Ifen-Infected: 0.622 ± 0.017, *n* = 565/10; Veh-transfected: 1.07 ± 0.035, *n* = 103/4; Ifen-transfected: 0.633 ± 0.051, *n* = 81/4; *p* \< 0.0001, one-way ANOVA). ***B***, Ifenprodil has the same effect on mSCaT frequency for transiently transfected cells as infected cells (Normalized frequency: Veh-infected: 0.82 ± 0.022, *n* = 961/20; Ifen-Infected: 0.137 ± 0.006, *n* = 788/10; Veh-transfected: 0.855 ± 0.063, *n* = 110/4; Ifen-transfected: 0.20 ± 0.048, *n* = 142/4; *p* \< 0.0001, one-way ANOVA). ***C***, Hippocampal neurons were infected with AAV-GFP or AAV-GCaMP6f at 0 DIV and harvested at 12 or 19 DIV. Representative immunoblots for GluN1, GluN2A, GluN2B, and α-tubulin are shown. Molecular weight markers (kD) indicated for each immunoblot. Sample from adult rat hippocampus (HC) included as positive control. ***D***, Quantitation shows decrease in GluN2B/GluN2A ratio from 12 to 19 DIV. Graph depicts normalized mean GluN2B/GluN2A ratios ± SEM (DIV factor: *p* \< 0.0001; Infection factor: *p* = 0.5009; Interaction: *p* = 0.812; two-way ANOVA). Download Figure 2-1, TIF file.

Ca^2+^ imaging analysis {#s3C}
-----------------------

To analyze the Ca^2+^ imaging data, averages of the first 50--100 frames were generated either in MATLAB or MetaMorph. On each averaged image, a circular region-of-interest (ROI) was drawn around every single spine that was in focus, distinct from the dendrite, and unobstructed, regardless of activity level, as well as a background ROI. Mean intensity within each region was measured for every frame using custom MATLAB scripts. Background subtraction was done by subtracting the average intensity of the background ROI from the average intensity of each spine ROI per frame. To calculate ΔF/F, *F*~baseline~ was determined for each spine ROI every minute by averaging fluorescence intensity every 10 frames, and within every minute interval of imaging finding the lowest positive value. Then for each frame (*F*~frame~ − *F*~baseline~)/*F*~baseline~ was calculated. To detect and measure peaks, the ΔF/F values were then fed into Clampex (Molecular Devices) where miniature spontaneous Ca^2+^ transients (mSCaTs) were detected using a template search that identified peaks based on an average shape profile. For measurements normalized to baseline, only spines that had at least three mSCaTs at baseline were included, typically ∼23--55% of all spines imaged. While for measurements that are not normalized, all spines are included for frequency data and spines with at least one mSCaT were used for amplitude data.

Spine and cell morphologic analysis {#s3D}
-----------------------------------

Spine area was measured using maximum projections of the post-Ca^2+^ imaging GCaMP6f *z*-stacks in MetaMorph. Within each spine ROI, an intensity-based threshold was used to calculate area. To measure synapse distance from the soma and branch depth, GCaMP6f *z*-stacks were imported into Imaris (Bitplane) for semiautomatic dendrite and spine detection. Spines identified in Imaris were matched to Ca^2+^ imaged spines using custom MATLAB scripts.

Immunocytochemistry {#s3E}
-------------------

For immunocytochemistry, cultured hippocampal neurons were fixed in 4% paraformaldehyde (PFA) and 4% sucrose directly following Ca^2+^ imaging for 20 min at room temperature (RT). Following fixation, coverslips were washed with PBS + glycine and permeabilized in PBS+ 0.3% Triton X-100 for 20 min at RT. Next, cells were incubated in blocking buffer containing 10% donkey serum (DS; Sigma-Aldrich) and 0.2% Triton X-100 for 1 h at room temperature. For labeling of Shank, cells were incubated in 1:200 anti-Shank primary (NeuroMab; RRID:[AB_10672418](https://scicrunch.org/resolver/AB_10672418)), 5% DS and 0.1% Triton X-100 for 3 h at RT. Followed by incubation with 1:200 AlexaFluor 647-conjugated goat anti-mouse secondary antibody (Jackson Laboratories) for 1 h at RT. Finally, cells were postfixed in 4% PFA and 4% sucrose for 10 min.

Super-resolution imaging and analysis {#s3F}
-------------------------------------

dSTORM imaging was performed on the Olympus IX-81 inverted microscope, using a 60×/1.42 oil-immersion objective along with Dragonfly multimodal system (Andor) and an iXon+ 897 EM-CCD camera (Andor). Cells that had undergone Ca^2+^ imaging were first located by eye in PBS, which was then replaced with STORM imaging buffer containing 50 m[m]{.smallcaps} Tris, 10m[m]{.smallcaps} NaCl, 10% glucose, 0.5 mg/ml glucose oxidase (Sigma-Aldrich), 40 µg/ml catalase (Sigma-Aldrich), and 0.1 [m]{.smallcaps} cysteamine (Sigma-Aldrich) before imaging. Acquisition was performed at 20 Hz, for a total of 70,000 frames while autofocusing every 1000 frames. Imaging was conducted in wide-field mode using the Dragonfly's beam expander set to a power density of 4 to concentrate the excitation beam.

All dSTORM analysis was done using custom MATLAB (MathWorks) scripts that fit peaks with an elliptical 2D Gaussian function to a 5 ×5 pixel array. The fitted peaks were used to determine *x* and *y* coordinates of the molecules. Molecules with a localization precision \<20 were used for analysis. PSD detection was performed using custom MATLAB scripts. Briefly, following localization detection and drift correction, the image was re-rendered with 14.75 nm pixels, and clusters of localizations exceeding the density cutoff of 1 localization per 217.6 nm^2^ were identified. Clusters with areas \<0.02 μm^2^, the bottom of the range reported for synapses imaged with super-resolution ([@B60]), were rejected. Spine Ca^2+^ data were matched to individual PSDs by overlaying super resolved PSDs on the GCaMP6f *z*-stack and manually matching spines between the post-STORM *z*-stack and the Ca^2+^ imaging time-lapse.

Immunoblotting {#s3G}
--------------

Hippocampal neuron cultures were prepared as described, infected at 0 DIV with AAV vectors, and plated at density of ∼100,000 cells per well in 12-well plate. Neurons were matured as described and at 12 or 19 DIV, neuronal cell homogenates were prepared in preheated buffer containing 1% SDS, 50 m[m]{.smallcaps} NaF, 1 m[m]{.smallcaps} sodium orthovanadate, and Phosphatase Inhibitor Cocktail I (Sigma-Aldrich) and Phosphatase Inhibitor Cocktail III (Sigma-Aldrich) supplemented with protease inhibitors (Roche cOmplete, EDTA-free). Homogenates were collected into microcentrifuge tubes, sonicated using manual ultrasonication probe, and heated at 65°C for 10 min. Protein concentration was determined by BCA assay (Pierce) and equal amounts of total protein (10 μg) from each sample were resolved by SDS-PAGE and transferred to PVDF membranes for detection by near-infrared fluorescence. Total protein stain was performed on all membranes (REVERT, LI-COR Biosciences). Immunoblot images were obtained on Odyssey Imaging System and quantitated using Image Studio 4.0 software (LI-COR Biosciences). NMDAR subunit protein levels were normalized against total protein signal for each lane. Quantitative plots were constructed using normalized mean values from six samples collected from each condition on each maturation day from a single culture. Data represent mean values ± SEM. Statistical analyses were conducted on quantitated values using GraphPad software.

Antibodies {#s3H}
----------

Membranes were blotted with primary antibodies including rabbit polyclonal anti-GluN1 C-terminus (1:2000; Sigma-Aldrich, catalog \#G8913; RRID:[AB_259978](https://scicrunch.org/resolver/AB_259978)), rabbit polyclonal anti-GluN2A N-terminus (1:500; JH6097 gift from R. Huganir, Johns Hopkins University), mouse monoclonal anti-GluN2B C-terminus (1:2000; Millipore, catalog \#05-920; RRID:[AB_417391](https://scicrunch.org/resolver/AB_417391)), and mouse monoclonal anti-α Tubulin (1:2000; Sigma-Aldrich, catalog \#T6074; RRID:[AB_477582](https://scicrunch.org/resolver/AB_477582)). Near-infrared-conjugated secondary antibodies were used to detect signal for GluN1 or GluN2A: donkey anti-rabbit 680RD (1:10 000; LI-COR Biosciences, catalog \#926-68073; RRID:[AB_10954442](https://scicrunch.org/resolver/AB_10954442)), GluN2B: donkey anti-mouse 800CW (1:10,000; LI-COR Biosciences, catalog \#926-32212; RRID:[AB_621847](https://scicrunch.org/resolver/AB_621847)), and α-tubulin: goat anti-mouse 680RD (1:10,000; LI-COR Biosciences, catalog \#926-68070; RRID:[AB_10956588](https://scicrunch.org/resolver/AB_10956588)).

Experimental design and statistical analysis {#s3I}
--------------------------------------------

Unless otherwise stated, the number of spines was \>200; however, treatment with ifenprodil or Mg^2+^ reduced event frequency so that there were fewer spines to use for mSCaT amplitude measurements post-treatment and unless otherwise stated these came from at least three separate culture preparations. Statistical analysis was performed using GraphPad Prism. Data are shown as mean ± SEM. Kruskal--Wallis followed by Dunn's test for multiple comparisons were used for experiments that had more than two groups; otherwise Student's *t* test was used to compare means at *p* \< 0.05. For experiments comparing the effect of a treatment between groups, post-treatment parameters were normalized to each spine's own baseline to assess the impact of the treatment. For correlations, Pearson's correlation coefficients were used to assess the strength of the relationship. When noted, data were binned into eight bins so that pattern in the data could be observed more clearly; however, no statistics were performed on binned data. Additionally, for data represented by violin plots, outliers were removed using the ROUT method of identifying outliers. However, all statistics were performed on the raw data before outlier removal. Significance of all results is reported as follows: ns, not significant; \**p* \< 0.05; \*\**p* \< 0.01; \*\*\*\**p* \< 0.0001.

Code accessibility {#s3J}
------------------

All MATLAB code used for Ca^2+^ and super-resolution imaging analysis is available on request. All code was run on Windows 7 and Windows 10 operating systems.

Results {#s4}
=======

Measuring NMDAR-mediated Ca^2±^ transients with GCaMP6f at individual synapses {#s4A}
------------------------------------------------------------------------------

To assess NMDAR activation by spontaneous neurotransmitter release, we sparsely infected dissociated rat hippocampal neurons at the time of plating with AAV expressing GCaMP6f, and imaged neurons at 19--22 DIV (unless otherwise noted) in ACSF containing 0 m[m]{.smallcaps} Mg^2+^, and 1 μ[m]{.smallcaps} TTX to block APs. Clear mSCaTs were detected in individual spines ([Fig. 1*A*](#F1){ref-type="fig"}) that were well isolated within spines and did not correspond to increases in Ca^2+^ in dendrites ([Fig. 1*B*](#F1){ref-type="fig"}). Though Ca^2+^ influx through NMDARs can lead to Ca^2+^ release from intracellular stores ([@B79]), we found that mSCaT amplitude in spines were unaffected by ryanodine and thapsigargin to prevent Ca^2+^-induced Ca^2+^ release (CICR) from internal stores (vehicle: 0.8164 ± 0.032 ΔF/F, *n* = 277 spines/7 neurons; blockers: 0.9206 ± 0.055 ΔF/F, mean ± SEM, *n* = 239/6; *p* = 0.095, unpaired *t* test; [Fig. 1*E*,*F*](#F1){ref-type="fig"}). Despite this, to ensure isolation of the NMDAR component of spine Ca^2+^ changes, all experiments were done in the presence of DNQX to block AMPARs, nifedipine to block L-type Ca^2+^ channels, and previously mentioned CICR blockers. Application of the NMDAR antagonist APV nearly eliminated all events (post-treatment event frequency normalized to baseline: vehicle: 0.9369 ± 0.03228, *n* = 495/10, APV: 0.05541 ± 0.008763, *n* = 197/5; *p* \< 0.0001, unpaired *t* test; [Fig. 1*G*,*H*](#F1){ref-type="fig"}), confirming that the observed Ca^2+^ transients were NMDAR-mediated.

To confirm that our measurement is sensitive to changes in NMDAR activation, we tested the dynamic range of GCaMP6f imaging at individual synapses. We reasoned that if the indicator is not near saturation, then increases in extracellular Ca^2+^ will produce approximately proportional increases in fluorescence intensity (F), otherwise very large Ca^2+^ influx will saturate the indicator and result in a disproportionately low ΔF/F. To test this, we raised the concentration of Ca^2+^ in the ACSF from 1.5 to 1.88 m[m]{.smallcaps} and measured mSCaT amplitude. We observed a significant increase in the average mSCaT amplitude (vehicle: 1.138 ± 0.031 ΔF/F, *n* = 611/17; 1.88 m[m]{.smallcaps} Ca^2+^: 1.56 ± 0.051 ΔF/F, *n* = 377/4; *p* \< 0.0001, Kruskal--Wallis; [Fig. 1*I*](#F1){ref-type="fig"}, and Extended Data [Fig. 1-1](#fig1-1){ref-type="supplementary-material"}), confirming that under our experimental conditions there was sufficient upper range to detect larger mSCaTs. To probe for sensitivity to smaller responses, and establish a lower limit to our detection, we added extracellular Mg^2+^ to block NMDAR channels, which we predicted would decrease the amplitude of mSCaTs. The IC~50~ of Mg^2+^ at a typical resting potential of −60 mV is ∼20 μ[m]{.smallcaps} for NMDARs ([@B56]). Increasing the extracellular Mg^2+^ concentration from 0 to 30 μ[m]{.smallcaps} caused a significant decrease of close to 50% in the range of mSCaT amplitudes, as expected (vehicle: 1.138 ± 0.031 ΔF/F, *n* = 611/17; 30 μ[m]{.smallcaps}: 0.697 ± 0.046 ΔF/F, *n* = 122/7; *p* \< 0.0001, Kruskal--Wallis; [Fig. 1*I*](#F1){ref-type="fig"} and Extended Data [Fig. 1-1](#fig1-1){ref-type="supplementary-material"}), confirming that there is sufficient sensitivity to detect smaller mSCaTs. Additionally, the sensitivity of the events to \[Mg^2+^\] further confirms that mSCaTs reflect the amount of NMDAR activation. To evaluate the lower limit of mSCaT detection, we raised the Mg^2+^ concentration again, to 100 μ[m]{.smallcaps} and 1 m[m]{.smallcaps}. Both concentrations decreased mSCaT amplitude (100 μ[m]{.smallcaps}: 0.513 ± 0.049 ΔF/F, *n* = 66/5; 1 m[m]{.smallcaps}: 0.31 ± 0.057 ΔF/F, *n* = 20/4; *p* \< 0.0001, Kruskal--Wallis; [Fig. 1*I*](#F1){ref-type="fig"} and Extended Data [Fig. 1-1](#fig1-1){ref-type="supplementary-material"}) and decreased mSCaT frequency (hertz; vehicle: 0.04 ± 0.002, *n* = 414/3; 100 μ[m]{.smallcaps}: 0.005 ± 0.0001, *n* = 132/5; 1 m[m]{.smallcaps}: 0.0004 ± 0.0002, *n* = 89/4; *p* \< 0.0001, Kruskal--Wallis). Interestingly, although the above Mg^2+^ experiments were performed in the absence of DNQX, we observed the same effects of Mg^2+^ in the presence of DNQX (data not shown).

Together, these observations suggest that under more physiologic conditions, AMPAR activation after spontaneous release does not alone cause sufficient depolarization to relieve the Mg^2+^ block on the NMDARs. This decrease in mSCaT frequency suggests that either a subset of events are too small to detect when Mg^2+^ is present, or that some synaptic NMDARs are effectively entirely blocked by Mg^2+^ at these concentrations. Measuring the distribution of individual mSCaTs in elevated Mg^2+^ revealed a lower ΔF/F limit of 0.1 ΔF/F, the amplitude of the smallest events observed, below which mSCaTs cannot be reliably detected. While we cannot deduce the true amount of Ca^2+^ influx from the GCaMP6f ΔF/F because of the nonlinearities inherent in the imaging approach, these data together indicate a large dynamic range of the reporter, and suggest it provides an acceptable readout of the strength of NMDAR activation at individual synapses. To ensure that NMDARs were minimally blocked, all other experiments were performed in the absence of added Mg^2+^.

Critically, we observed that mSCaT amplitudes and frequencies were highly variable between synapses ([Fig. 1*C*,*D*](#F1){ref-type="fig"}) with population inter-spine Cs of 0.64 and 0.99, respectively. Interestingly, the mean within-spine coefficient of variation (CV) for event amplitude was also quite high, nearly at the level as what was observed between spines (0.57 ± 0.01 *n* = 700/10, at least 3 events per spine). This variability was not because of differences in co-agonist availability, as treatment with 100 μ[m d-]{.smallcaps}serine actually increased intra-spine mSCaT variability (mean CV normalized to baseline: vehicle: 1.05 ± 0.05, *n* = 159/4; [d-]{.smallcaps}serine: 1.28 ± 0.05, *n* = 252/4; *p* = 0.002, unpaired *t* test). We therefore asked what synaptic or receptor properties could underlie this high degree of variability in receptor activation by spontaneous release both within and between synapses.

GluN2B-NMDARs mediate the majority of the NMDAR-dependent Ca^2±^ influx by spontaneous release {#s4B}
----------------------------------------------------------------------------------------------

A critical regulator of NMDAR function and downstream signaling is the composition of its GluN2 subunit. Specifically, GluN2B-NMDARs are important mediators of synaptic plasticity ([@B29]; [@B84]; [@B92]), which makes them well suited to mediate the plasticity induced by changes in spontaneous NMDAR activation. Therefore, we asked what proportion of mSCaTs in mature synapses is comprised of GluN2B-NMDARs activation. To address this, we imaged GCAMP6f before and after bath application of the GluN2B-specific antagonist ifenprodil (6 μM), or vehicle ([Fig. 2*A*, *B*](#F2){ref-type="fig"}). Ifenprodil at this concentration is expected to nearly completely block GluN2B-NMDARs, block ∼20% of GluN2A/B-NMDARs, and have almost no effect on GluN2A-NMDARs ([@B97]). In our cells, treatment with ifenprodil caused a ∼35% reduction in mSCaT amplitude (normalized amplitude: vehicle: 0.977 ± 0.015, *n* = 1204/20; ifenprodil: 0.622 ± 0.017, *n* = 572/10; *p* \< 0.0001, Kruskal--Wallis; [Fig. 2*C*,*E*](#F2){ref-type="fig"}). Interestingly, we observed a dramatic reduction in mSCaT frequency following application of ifenprodil, with ∼30% of synapses completely silenced by ifenprodil application and an ∼81% reduction in overall mSCaT frequency \[normalized frequency: vehicle: 0.82 ± 0.022, *n* = 961/20; ifenprodil (3 weeks): 0.138 ± 0.006, *n* = 788/10; *p* \< 0.0001, Kruskal--Wallis; [Fig. 2*D*,*F*](#F2){ref-type="fig"}\]. The dramatic drop in event frequency along with complete blockade of events at half of the synapses suggests a significant portion of mSCaTs are entirely GluN2B-NMDAR mediated, and that GluN2A-NMDARs contribute very little to NMDAR-mediated Ca^2+^ influx in response to spontaneous release.

![GluN2B-NMDARs mediate majority of response to spontaneous glutamate release. ***A***, Average projection of GCaMP6f (green) at baseline and following treatment with vehicle or ifenprodil. Active synapses are shown in magenta. Following treatment with ifenprodil there is a clear reduction in the number of active spines compared with baseline. Scale bar, 10 μm. ***B***, Example traces from spines treated with either vehicle (black) or ifenprodil (red). ***C***, Ifenprodil treatment leads to a reduction in mSCaT amplitude at both 3 and 5 weeks. Outliers removed for data display. Solid line represents median and dashed lines indicate 1st and 3rd quartile. Second plot is cumulative probability for all spines. For immunoblotting data, see Extended Data [Figure 2-1](#fig2-1){ref-type="supplementary-material"} and Extended Data [Figure 2-2](#fig2-2){ref-type="supplementary-material"}. ***D***, Ifenprodil treatment leads to a reduction in mSCaT frequency at both 3 and 5 weeks. Outliers removed for data display. Solid line represents median and dashed lines indicate 1st and 3rd quartile. Second plot is cumulative probability for all spines. ***E***, Post-treatment mSCaT amplitude versus baseline mSCaT amplitude has a slope of 0.6167 ± 0.033 for vehicle-treated cells and 0.327 ± 0.025 for ifenprodil-treated cells and these slopes are significantly different (*p* \< 0.0001). Post-treatment mSCaT amplitude is correlated with baseline amplitude for both vehicle-treated synapses (*R*^2^=0.42, *p* \< 0.0001) and ifenprodil-treated synapses (*R*^2^=0.22, *p* \< 0.0001). ***F***, Baseline mSCaT frequency versus post-treatment mSCaT frequency reveals that nearly all synapses show a reduction in event number with ifenprodil treatment (vehicle: slope= 0.7984 ± 0.02368; ifenprodil: slope = 0.108 ± 0.005452; *p* \< 0.0001). Post-treatment mSCaT amplitude is correlated with baseline amplitude for both vehicle-treated synapses (*R*^2^=0.56, *p* \< 0.0001) and ifenprodil-treated synapses (*R*^2^=0.31, *p* \< 0.0001). ***G***, Normalized amplitude post-ifenprodil treatment is negatively correlated with baseline amplitude. ***H***, Normalized mSCaT frequency post-ifenprodil treatment is negatively correlated with baseline mSCaT frequency. ***I***, Within spine CV decreases following ifenprodil treatment. ***J***, Three micromolar ifenprodil (blue) treatment leads to a significant reduction in mSCaT frequency. Outliers removed for data display in violin plots. Second plot is cumulative probability for all spines. ***K***, Three micromolar ifenprodil (blue) treatment leads to a significant reduction in mSCaT amplitude. Outliers removed for data display in violin plots. Second plot is cumulative probability for all spines. ***L***, Ro 25-6981 (green) treatment leads to a significant reduction in mSCaT frequency. Outliers removed for data display in violin plots. Second plot is cumulative probability for all spines. ***M***, Ro 25-6981 (green) treatment leads to a significant reduction in mSCaT amplitude. Outliers removed for data display in violin plots. Second plot is cumulative probability for all spines. ns, not significant; \**p* \< 0.05; \*\**p* \< 0.01; \*\*\*\* *p* \< 0.0001.](enu0031929450002){#F2}
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Representative full immunoblots from Figure 2-1. ***E***, Full blot of REVERT protein stain. Download Figure 2-2, TIF file.

Additionally, because GluN2B-NMDAR levels are developmentally regulated in some brain areas ([@B18]; [@B9]; [@B81]; [@B115]), we imaged neurons at 5 weeks, to assess whether the large effect of ifenprodil on mSCaT frequency was because of the age of the cells. We found a significant reduction in amplitude and frequency with ifenprodil in 5 week cells \[normalized amplitude (5 weeks): 0.608 ± 0.049, *n* = 94/9; normalized frequency (5 weeks): 0.196 ± 0.022, *n* = 130/9; *p* \< 0.0001, Kruskal--Wallis\], and no difference between the effects of ifenprodil on 3 or 5-week-old neurons (amplitude: *p* = 0.546, Kruskal--Wallis; frequency: *p* = 0.0247, Kruskal--Wallis; [Fig. 2*C*,*D*](#F2){ref-type="fig"}), indicating that GluN2B-NMDARs contribute significantly to spontaneous events in mature cultured hippocampal neurons of different ages. It is conceivable that expression of GCaMP6f, by chronic alteration of Ca^2+^ buffering in the cell, could lead to abnormal expression of GluN2 subunits and prevent the typical developmental shift in the ratio of GluN2B:GluN2A subunits ([@B115]). To test this, we examined subunit expression levels at 12 and 19 DIV in control cultures, or in cultures that had been infected with GCaMP6f or GFP. In uninfected cultures, we observed the expected decrease in the ratio, and this decrease was unaltered in either virus-infected condition (Extended Data [Fig. 2-1*C*,*D*](#fig2-1){ref-type="supplementary-material"} and Extended data [Fig. 2-2](#fig2-2){ref-type="supplementary-material"}). We then examined ifenprodil sensitivity in neurons that were only transiently transfected with GCaMP6f, rather than infected. We found that neurons that expressed GCaMP6f from 18--21 DIV showed the same high ifenprodil sensitivity as those chronically expressing via virus infection (Normalized amplitude: Veh-infected: 0.98 ± 0.016, *n* = 1204/20; Ifen-infected: 0.622 ± 0.017, *n* = 572/10; Veh-transfected: 1.07 ± 0.035, *n* = 103/4; Ifen-transfected: 0.633 ± 0.051, *n* = 81/4; *p* \< 0.0001, one-way ANOVA; Normalized frequency: Veh-infected: 0.82 ± 0.022, *n* = 961/20; Ifen-infected: 0.137 ± 0.006, *n* = 788/10; Veh-transfected: 0.855 ± 0.063, *n* = 110/4; Ifen-transfected: 0.20 ± 0.048, *n* = 142/4; *p* \< 0.0001, one-way ANOVA; Extended Data [Fig. 2-1*A*,*B*](#fig2-1){ref-type="supplementary-material"}). These observations suggest that chronic GCaMP6f expression does not alter subunit expression.

Returning to further analysis of virally infected neurons, we also observed that synapses with larger mSCaTs at baseline were associated with a greater effect of ifenprodil on mSCaT amplitude (*R* ^2^ = 0.089, *p* \< 0.0001, *n* = 544/10; [Fig. 2*G*](#F2){ref-type="fig"}), and spines with higher mSCaT frequency at baseline tended to have a larger portion of events blocked with ifenprodil (*R* ^2^ = 0.012, *p* = 0.003, *n* = 751/10; [Fig. 2*H*](#F2){ref-type="fig"}). Thus, more active synapses, with more NMDAR activation, have a larger contribution of GluN2B-containing NMDARs to their events. Because GluN2B-NMDARs have longer open times and lower open probability than GluN2A-NMDARs, it is likely that there is increased variability in Ca^2+^ influx through GluN2B-NMDARs ([@B85]). Indeed, we observed that mSCaT amplitude variance was slightly reduced following ifenprodil treatment (baseline CV: 0.633 ± 0.02; post-ifenprodil CV: 0.495 ± 0.016; *n* = 225, *p* \< 0.0001, paired *t* test; [Fig. 2*I*](#F2){ref-type="fig"}), however, this could at least be partially because of the large reduction in the number of events. Overall, NMDAR subtype may contribute to the high degree of variability in NMDAR-mediated Ca^2+^ influx. Together, these results not only indicate that GluN2B-NMDARs contribute to events at these synapses, but also that a significant portion of mSCaTs are largely GluN2B-NMDAR mediated.

Finally, because 6 μ[m]{.smallcaps} ifenprodil can to some extent block NMDARs subtypes other than GluN1/GluN2B diheteromeric NMDARs ([@B44]; [@B39]; [@B98]), we also treated cells with 3 μ[m]{.smallcaps} ifenprodil or 1 μ[m]{.smallcaps} Ro 25-6981. At 3 μ[m]{.smallcaps}, ifenprodil still is expected to block nearly all GluN2B-NMDARs, but the off-target effects on GluN2A-NMDARs and GluN2A/B-NMDARs should be reduced ([@B44]; [@B39]; [@B98]). In a separate set of experiments in which matched neurons were treated with vehicle, 3 μ[m]{.smallcaps}, or 6 μ[m]{.smallcaps} ifenprodil, each concentration strongly reduced mSCaT frequency ([Fig 2*J*](#F2){ref-type="fig"}). In fact, the effect at 3 μ[m]{.smallcaps} was slightly stronger (vehicle: 0.829 ± 0.0974, *n* = 126/8; ifen 3 μ[m]{.smallcaps}: 0.251 ± 0.0229, *n* = 235/10; ifen 6 μ[m]{.smallcaps}: 0.379 ± 0.0257, *n* = 349/9; *p* \< 0.0001, Kruskal--Wallis; [Fig. 2*J*](#F2){ref-type="fig"}). This is consistent with the idea that the effect of ifenprodil on mSCaT frequency is because of blockade of GluN2B-NMDARs rather than other NMDAR subtypes. Interestingly, although there was a significant decrease in mSCaT amplitude with 3 μ[m]{.smallcaps} ifenprodil, it was less pronounced than the effect of 6 μ[m]{.smallcaps} ifenprodil on amplitude (vehicle: 1.022 ± 0.0484, *n* = 106/8; ifen 3 μ[m]{.smallcaps}: 0.8119 ± 0.0385, *n* = 132/10; ifen 6 μ[m]{.smallcaps}: 0.647 ± 0.0203, *n* = 241/9; *p* \< 0.0001, Kruskal--Wallis; [Fig. 2*K*](#F2){ref-type="fig"}). The difference in amplitude reduction with 3 and 6 μ[m]{.smallcaps} ifenprodil suggests that some of the reduction in mSCaT amplitude observed with 6 μ[m]{.smallcaps} ifenprodil may be because of blockade of GluN2A/B or GluN2A-NMDARs at individual synapses.

We next explored the effects of Ro 25-6981, a related compound which is more specific than ifenprodil for GluN2B-NMDARs compared with GluN2A-NMDARs ([@B28]), though unfortunately the effects of Ro 25-6981 on triheteromeric receptors are unknown. Treatment with Ro 25-6981 had a similar effect on mSCaT frequency as ifenprodil (vehicle: 0.69 ± 0.035, *n* = 435/17; Ro 25-6981: 0.283 ± 0.027, *n* = 547/18; *p* \< 0.0001, unpaired *t* test; [Fig. 2*L*](#F2){ref-type="fig"}), thus further supporting the role of GluN2B-NMDARs in responding to spontaneous glutamate release. Similar to the effect of 3 μ[m]{.smallcaps} ifenprodil, the reduction in mSCaT amplitude was smaller than observed with 6 μ[m]{.smallcaps} ifenprodil while still significant (vehicle: 1.013 ± 0.025, *n* = 367/17; Ro 25-6981: 0.917 ± 0.025, *n* = 232/18; *p* = 0.009, unpaired *t* test; [Fig. 2*M*](#F2){ref-type="fig"}). Together, the reduction in mSCaT frequency by 3 μ[m]{.smallcaps} ifenprodil or Ro 25-6081 confirms that GluN2B-containing NMDARs are the primary NMDAR subtype activated by spontaneous release at nearly all synapses in this preparation.

NMDAR activation is independent of spine and synapse size {#s4C}
---------------------------------------------------------

Whereas GluN2B-NMDARs contribute to variability of mSCaT amplitude within synapses, other parameters may contribute to variability between synapses. Although there is evidence that the number of NMDARs present in the PSD ([@B55]; [@B104]; [@B90]; [@B20]) as well as the magnitude of their activation by evoked release is not related to spine size ([@B70]), there is a strong relationship between spine size and the amount of activation of other receptor types, particularly AMPARs ([@B27]; Matsuzaki et al., 2004; [@B5]). Because NMDAR activation by spontaneous release may be regulated distinctly from NMDAR activation by evoked release, we tested the relationship between mSCaTs and spine size. We measured spine area at individual synapses based on post-Ca^2+^ imaging *z*-stacks ([Fig. 3*A*,*B*](#F3){ref-type="fig"}). Spine area ranged from 0.163 to 1.411 μm^2^ with a mean spine area of 0.639 ± 0.009 μm^2^. By matching spine area to mSCaT data for each synapse, we found that mean mSCaT amplitude per spine was weakly negatively correlated with spine area for spontaneous release events (*R* ^2^ = 0.008, *p* = 0.028, *n* = 628/10). A similar result was seen with binned spine area data to reduce overpowering the analysis (*R* ^2^ = 0.256, *p* = 0.023, *n* = 20/10; [Fig. 3*C*](#F3){ref-type="fig"}). However, this negative correlation is likely because of smaller proportional Ca^2+^ influx in larger spines rather than differences in the amount of NMDAR activation ([@B70]). Overall, this suggests that NMDAR activation does not substantially scale with spine size.

![NMDAR activation is independent of spine area. ***A***, Example stretch of dendrite from post-Ca^2+^ imaging GCaMP6f *z*-stack. Scale bar, 10 μm. ***B***, Zoom in of spines indicated by white arrowheads from ***A*** paired with their respective Ca^2+^ traces. Scale bar, 1 μm. ***C***, mSCaT amplitude weakly, negatively correlates with spine area. First plot is all spines, second plot binned data. ***D***, Effect of ifenprodil on amplitude (light red) and frequency (dark red) does not correlate with spine area. Left plot is all spines; right plot is binned data. ***E***, GCaMP6f max projection acquired directly following Ca^2+^ imaging (scale bar, 20 μm) of dSTORM imaged neuron. White box indicates area where super-resolution imaging was performed. ***F***, Zoom in on the region from ***E***. Max projection of GCaMP6f stack acquired at time of STORM imaging (white). Scale bar, 5 μm. Super-resolved shank localizations are shown in red. Right, Zoom-in of the shank localizations from the spine indicated with the yellow arrowhead. ***G***, Zoom-in of a mSCaT in the spine indicated by yellow arrowhead in ***F***. ***H***, Ca^2+^ trace from spine indicated by yellow arrowhead in ***F***. ***I***, Amplitude does not correlate with PSD area.](enu0031929450003){#F3}

GluN2B-NMDARs have been shown to exit synapses that have undergone LTP ([@B26]) and those synapses tend to be larger ([@B64], 2004; [@B61]). Therefore, it is possible there is a smaller contribution of GluN2B-NMDARs at larger spines. To address this, we examined the correlation between the effect of ifenprodil on mSCaTs at individual synapses and spine area. We found that spine area did not correlate with the magnitude of ifenprodil blockade on amplitude or frequency of mSCaTs (normalized amplitude: raw: *R* ^2^ = 0.006, *p* = 0.388, *n* = 127/6; binned: *R* ^2^ = 0.050, *p* = 0.342, *n* = 20/6; normalized frequency: *R* ^2^ = 0.012, *p* = 0.109, *n* = 221/6; binned: *R* ^2^ = 0.059, *p* = 0.298, *n* = 20/6; [Fig. 3*D*](#F3){ref-type="fig"}). These data suggest that the contribution of GluN2B-NMDARs per synapse is not related to spine area.

Although spine size is often related to synapse size ([@B43]), the PSD is much smaller than the spine itself, and is a highly dynamic structure that is strongly correlated to the size of the active zone across the cleft ([@B42]; [@B89]; [@B48]; [@B60]). Thus, to measure the area of the PSD itself using super-resolution microscopy, we turned to dSTORM imaging of the postsynaptic protein Shank. We matched mSCaT data to super-resolved PSDs for 47 synapses from 6 neurons that were subjected to live GCaMP6f imaging followed by fixation and anti-Shank immunocytochemistry and dSTORM imaging ([Fig. 3*E*--*H*](#F3){ref-type="fig"}). The mean PSD area was 0.060 ± 0.006 μm^2^, which is near the mean reported by electron microscopy of hippocampal synapses (mean ∼0.069 μm^2^; [@B42]; [@B89]; [@B90]). We found that mSCaT amplitude was not correlated with PSD area (*R* ^2^ = 0.013, *p* = 0.452, *n* = 47/6; [Fig. 3*I*](#F3){ref-type="fig"}).

Together, this set of observations indicates that the size of the activated pool of NMDARs at individual synapses is independent of synapse size and that variability in the magnitude of NMDAR activation observed between synapses for spontaneous release events is controlled by factors other than the size of the synapse itself.

mSCaT amplitude is correlated with synapse distance from the soma {#s4D}
-----------------------------------------------------------------

Another potential source of variability in mSCaT amplitude and frequency is the position of the synapse within the dendritic tree. In fact, NMDAR-mediated Ca^2+^ influx has been shown to be increased in synapses further from the cell body ([@B109]). We asked whether NMDAR activation by spontaneous glutamate release varies throughout the dendritic arbor as a function of distance from the soma or the number of branch points away from the soma (branch depth). We mapped neuronal morphology and identified spines along dendrites from *z*-stacks of GCaMP6f-expressing neurons using semiautomatic neuron tracing and spine detection in Imaris ([Fig. 4*A*--*C*](#F4){ref-type="fig"}) and identified spines in the traced image that had been Ca^2+^ imaged (Extended Data [Fig. 4-1](#fig4-1){ref-type="supplementary-material"}). Mean mSCaT amplitude per spine was significantly correlated with distance from the soma (*R*^2^ = 0.014, *p* = 0.036, *n* = 316/9; [Fig. 4*C*](#F4){ref-type="fig"}), as expected ([@B109]). Interestingly, although branch depth was correlated with distance from the soma (*R*^2^= 0.022, *p* \< 0.0001; data not shown), branch depth did not correlate with mean mSCaT amplitude (raw data: *R*^2^ = 0.0007, *p* = 0.649, *n* = 287/9; [Fig. 4*E*](#F4){ref-type="fig"}). To compare spines that are farther than ∼200 μm away from the soma, we repeated these experiments using a lower-power objective to increase the field-of-view. This allowed for a larger field-of-view and measurement of distances up to ∼450 μm away from the soma. We observed that even at these longer distances, there was a correlation between mSCaT amplitude and distance from soma (*R*^2^= 0.041, *p* \< 0.0001, *n* = 746/6; [Fig. 4*D*,*E*](#F4){ref-type="fig"}). Interestingly, when mSCaT amplitude was compared with branch depth at longer distances there was a correlation between mSCaT amplitude and branch depth (*R*^2^=0.018, *p* = 0.0002, *n* = 746/6; [Fig. 4*H*,*I*](#F4){ref-type="fig"}). These results demonstrate that the amount of NMDAR activation following spontaneous single vesicle release is related to the synapse distance from soma, and branch depth at more distal branches.

![Mapping synapse position and mSCaT characteristics with Imaris. ***A***, Ca^2+^ imaged spines along traced dendrite from Imaris. Scale bar, 30 μm. First panel shows distance from soma, second panel shows branch depth, and third panel shows mSCaT amplitude. Colors are warmer as spines that are farther from the cell body, have higher branch depth, or have larger mSCaT mean amplitudes respectively. For example of Imaris tracing see Extended Data [Figure 4-1](#fig4-1){ref-type="supplementary-material"}. ***B***, Zoom-in of boxed areas from ***A***. ***C***, mSCaT amplitude did correlate with distance from soma for proximal spines. ***D***, mSCaT amplitude did correlate with distance from soma when distal spines are included. ***E***, Binned data from ***D*** demonstrating relationship between spine distance from the soma and mSCaT amplitude ***F***, Magnitude of ifenprodil effect on mSCaT amplitude (light red) and frequency (dark red) does not correlate with distance from the soma. ***G***, mSCaT amplitude did not correlate with the number of branch points away from the soma the synapse is (branch depth) for proximal spines. ***H***, mSCaT amplitude does correlate with branch depth when distal spines are included. ***I***, Mean mSCaT amplitude at each branch depth. ***J***, Magnitude of ifenprodil effect on mSCaT amplitude (light red) and frequency (dark red) did not correlate with branch depth.](enu0031929450004){#F4}
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Imaris tracing examples. ***A***, Max projection of GCaMP6f stack taken following GCaMP6f imaging. Zoom-in of white box is on the right. Scale bars, 30 μm. ***B***, Semiautomatic spine detection on max projection of GCaMP6f. Blue spines are spines that do not have Ca^2+^ imaging data, whereas spines in red do. Zoom-in of white box is on the right. Scale bars, 30 μm. ***A***, Semiautomatic dendrite and spine detection in Imaris detects dimensions of cell features based on fluorescence. Download Figure 4-1, TIF file.

We then further asked whether GluN2B-NMDAR content varied based on synapse position. We found no correlation between the magnitude of the effect of ifenprodil with either distance from the soma (normalized frequency: raw data: *R* ^2^= 0.007, *p* = 0.237, *n* = 209/9; binned data: *R* ^2^= 0.036, *p* = 0.422, *n* = 20/9; normalized amplitude: raw data: *R* ^2^= 0.006, *p* = 0.367, *n* = 132/9; binned data: *R* ^2^= 0.034, *p* = 0.434, *n* = 20/9; [Fig. 4*F*](#F4){ref-type="fig"}) or branch depth (normalized frequency: raw data: *R* ^2^= 0.005, *p* = 0.315, *n* = 209/9; binned data: *R* ^2^= 0.007, *p* = 0.721, *n* = 209/9; normalized amplitude: raw data: *R* ^2^= 0.0009, *p* = 0.729, *n* = 20/9; binned data: *R* ^2^= 0.00004, *p* = 0.978, *n* = 20/9; [Fig. 4*J*](#F4){ref-type="fig"}). Therefore, the amount of GluN2B-NMDAR activation is independent of synapse position within the dendritic arbor.

Overall, synapse position did loosely correlate with mSCaT amplitude, whereas spine and synapse size did not. Furthermore, the GluN2B component of mSCaTs is also independent of synapse size and position. Therefore, it likely that there are other factors besides size or position that are responsible for the dramatic variability in spontaneous NMDAR activation between synapses.

Discussion {#s5}
==========

In the present study, we used an all-optical approach to characterize NMDAR activation following AP-independent (spontaneous) vesicle exocytosis at individual synapses of cultured hippocampal neurons. Whereas GCaMP6f has frequently been used to measure mSCaTs ([@B2]; [@B93]; [@B105]; [@B109]), we clarified that it offers a large dynamic range and permits detailed analysis of the magnitude of receptor activation. Using this approach, we found that at nearly all synapses in this preparation, GluN2B-NMDARs are the major NMDAR subtype activated during spontaneous synaptic transmission. Additionally, we observed a surprising degree of variability in mSCaT amplitude both between and within synapses. In fact, the variation at single spines was comparable to the between-spine variation, which suggests that Ca^2+^ influx through the receptor may be surprisingly independent of synapse-specific features such as the number of receptors present at the synapse. Indeed, we demonstrated that spine size, PSD area, and synapse position have a relatively small impact on mSCaTs. Therefore, this high degree of variability is likely to be dominated by differences in release position, variations in the amount of glutamate per vesicle, and random fluctuations in channel open time.

We found that even in the absence of an AMPAR antagonist, application of 1 m[m]{.smallcaps} Mg^2+^, which is still below the physiologic concentration, nearly eliminates all observable mSCaTs. This suggests that under more physiologic conditions, in the absence of other activity, many spontaneous release events do not lead to sufficient membrane depolarization to relieve the Mg^2+^ block on NMDARs, and thus result in little or no Ca^2+^ influx. Recent evidence demonstrates that glutamate binding to NMDARs can induce conformational changes in the receptor which lead to metabotropic signaling even in the absence of ion flux ([@B68]; [@B24], [@B25]). Importantly, this type of NMDAR activation can mediate some forms of plasticity ([@B54]; [@B4]; [@B23]; [@B96]; [@B113]). Thus, our data suggest that under physiologic conditions, effects of NMDAR activation by single-vesicle release events could be mediated principally by non-ionotropic functions rather than via Ca^2+^ influx.

Our data demonstrate that GluN2B-NMDARs contribute significantly to spontaneous events at all synapses and, at approximately half of synapses, are the primary NMDAR type activated by spontaneous release. This was somewhat surprising given the prevailing notion that GluN2B-NMDARs are not present at synapses after early development ([@B18]; [@B9]; [@B81]; [@B115]). However, this is consistent with other reports ([@B93]; [@B109]) and a large and growing amount of evidence suggests that GluN2B-NMDARs are found at mature hippocampal synapses ([@B52]) and they contribute significantly to synaptic events ([@B36]; [@B114]; [@B57]). Thus, although it is clear that in some brain areas a developmental switch in NMDAR subtype is pronounced, in the hippocampus it is not as prominent. Spontaneous NMDAR activation has specialized functions within the synapse ([@B99], [@B100]; [@B51]; [@B2]), and it is possible that these functions are specifically driven by GluN2B-NMDAR activation, rather than NMDAR activation in general. It will be important to assess whether GluN2B-NMDARs are required for the downstream signaling induced by spontaneous release.

We observed not only a large contribution of GluN2B-NMDARs to mSCaTs, but also a striking lack of Ca^2+^ influx mediated by GluN2A-NMDARs. Data regarding the contribution of NMDAR subtype to synaptic responses to spontaneous glutamate release has been mixed. In previous reports, knock-out of GluN2A-NMDARs reduced or eliminated NMDA-mEPSCs in mature midbrain synapses ([@B107]; [@B118]), thus suggesting that GluN2A-NMDARs are the principle responders to spontaneous release. This may be a region-specific effect, or, because GluN2A-NMDARs are essential for normal development of synapses in many brain regions ([@B34]; [@B36]; [@B49]), it is possible that global GluN2A knock-out alters synapses in other, unexpected ways.

Although GluN2A-NMDARs did not contribute significantly to mSCaTs here, they are present at hippocampal synapses in culture and function in evoked neurotransmission ([@B60]; [@B114]; [@B52]). Why are they less activated by spontaneous release? One option is that there is segregation of NMDARs such that the receptors activated by spontaneous release form a distinct pool, either a subset of or separate from those activated by evoked release. There is evidence to support this idea ([@B7]; [@B80]), and it possible that NMDAR subtype is specific to one pool or the other. A potential mechanism for restricting NMDAR activation is spatial segregation within the synapse. Indeed, within synapses, receptors are found to have a distinct nanoscale organization with subsynaptic high-density nanoclusters of postsynaptic proteins and AMPARs as well as GluN2B-NMDARs ([@B33]; [@B60]; [@B69]). Moreover, importantly, these postsynaptic nanodomains are aligned with presynaptic evoked release sites ([@B105]). Recently it has been demonstrated that within individual synapses, GluN2A- and GluN2B-NMDARs form distinct nanodomains that differ in size, number, and internal density ([@B52]), further consistent with the idea that nano-organization could influence which receptor type is activated. Interestingly because of their biophysical properties, GluN2B-NMDARs are especially likely to be sensitive to their positioning with respect to the site of release; receptors within ∼50 nm of the site of release three times more likely to open than those located ∼200 nm from the site of release ([@B85]). Therefore, the position of release site with respect to NMDARs may restrict not just the total amount of NMDAR activation but also which synaptic NMDARs are able to be activated by spontaneous release. Further, mapping of release sites during spontaneous and evoked release revealed that these release modes display different spatial patterns within the active zone ([@B105]). Given the possibility that GluN2B-NMDARs are positioned within the synapses as to be relevant for spontaneous release, the contribution of GluN2B-NMDARs to events in mature synapses may have been underestimated because of a focus on evoked release.

In addition to GluN2B-NMDARs and GluN2A-NMDARs, mature hippocampal synapses are thought to contain a significant population of triheteromeric receptors (GluN2A/B-NMDARs; [@B78]; [@B72]; [@B106]; [@B98]). Unfortunately, these are difficult to study *in situ* because of a lack of specific pharmacological agents. Based on dose-inhibition curves for ifenprodil for the different receptor subtypes, the 6 μ[m]{.smallcaps} ifenprodil concentration used here is likely to have blocked nearly all GluN2B-NMDAR activation\\with little impact on GluN2A-NMDARs, but also inhibited ∼20% of GluN2A/B-NMDAR-mediated responses ([@B71]; [@B39]; [@B97]). This probable effect on triheteromeric receptors may indicate that these receptors contribute to some spontaneous events. Indeed, the reduction in mSCaT amplitude was less dramatic with 3 μ[m]{.smallcaps} ifenprodil and Ro 25-6981, though still present. The consistent effects with these three antagonists strongly suggest that GluN2A-NMDARs do not significantly contribute to the responses we observed. However, to our knowledge it is not published or known whether Ro 25-6981 can inhibit triheteromeric receptors, nor whether it does so less effectively than ifenprodil, so the precise proportion of GluN2B and triheteromeric receptor contribution remains unclear. Nevertheless, based on the dramatic reduction in the number of events with 3 μ[m]{.smallcaps} ifenprodil treatment and the consistency across drug treatments, it is likely that GluN2B-NMDARs mediate the majority of the Ca^2+^ influx because of spontaneous release at these synapses.

We observed a high degree of variability in mSCaT amplitude both between and within synapses. Differences in the number of receptors activated per event or the NMDAR subtype activated could underlie variability in event amplitude. If the number of NMDARs activated per event was dominating this inter-event variability, then this would lead to the prediction that some synapses with more NMDARs, or a higher density of NMDARs apposed to release sites would have overall larger events. One consequence of this would be that the variability within a single synapse would be smaller than the variability between synapses. However, we observed a similar amount of mSCaT amplitude variability within synapses as between synapses, thus difference in the number of NMDARs able to be activated between synapses is not likely the dominant source of variability. GluN2B-NMDARs have longer open times and longer burst duration than GluN2A-NMDARs but have a much lower open probability, suggesting that they may contribute more to variability in the amount of Ca^2+^ influx per event ([@B85]). In fact, in single-channel recordings, ifenprodil reduces variability of NMDAR total open time ([@B73]). Consistent with this prediction, we observed there was a decrease in mean CV of mSCaT amplitude from 0.6 to 0.5 following ifenprodil treatment. This suggests that variability in Ca^2+^ influx through GluN2B-NMDARs substantially contributes to the differences in mSCaT amplitude between events, and that Ca^2+^ influx through activated GluN2A-NMDARs is less variable.

Spine size was not substantially correlated with the amount of Ca^2+^ influx per event. Similarly, NMDAR activation does not scale with spine size following glutamate uncaging ([@B95]; [@B103]) or evoked release ([@B70]). Together, these observations indicate that the amount of NMDAR activation is independent from spine size for both release modes. Another spine feature that may alter mSCaT amplitude and contribute to variability is spine neck diameter, because this could alter Ca^2+^ retention in the spine ([@B102]) Additionally, although we did not measure a strong correlation between spine size and mSCaT amplitude, it is nevertheless possible that small fluctuations in spine area during the course of the experiment could contribute slightly to the variability observed in mSCaT amplitude. Furthermore, PSD size measured with correlative super-resolution imaging was also unrelated to NMDAR activation. We did observe a weak negative correlation between spine size and mSCaT amplitude, however, we suspect that this is because of a decrease not in actual Ca^2+^ influx, but in the ratio of Ca^2+^ influx to total GCaMP6f in the compartment (that is, very large spines have a large basal *F*).

It is worth highlighting this novel combination of super-resolution imaging with functional measures at individual synapses. Nanoscale protein organization is hypothesized to control many aspects of synaptic function and signaling ([@B13]; [@B21]; [@B12]; [@B15]), so this correlative approach will be important for future tests of how NMDAR activation is impacted by other nanoscale synaptic features, such as the presence of subsynaptic scaffold nanoclusters ([@B33]; [@B60]; [@B69]; [@B14]; [@B105]). Rapidly improving and diversifying sensors for neurotransmitters and intracellular messengers ([@B62]; [@B67]; [@B82]), also suggest that it will be possible to more directly measure the link between synapse nanostructure and both the ionotropic and non-ionotropic activity of the receptor. Conversely, synaptic function can alter subsynaptic protein distributions, potentially mediating aspects of functional plasticity ([@B35]; [@B17]). We anticipate the correlative approach will be integral for exploration of dynamic synaptic signaling.

In another series of experiments, we asked whether synapse distance from the soma or degree of branch complexity plays a role in variability in the amount of NMDAR activation. Previous work has suggested that NMDAR-mediated Ca^2+^ influx is larger at synapses further away from the soma ([@B109]). Our data were consistent with this finding and revealed a significant correlation of mSCaT amplitude with the distance of the synapse from the soma, but not with branch complexity. However, there is evidence that spine size is correlated with distance from the soma and that more distal synapses tend to be smaller than those more proximal ([@B50]; [@B109]). Therefore, the relationship between spine distance and event amplitude may in part arise simply from a larger proportional Ca^2+^ influx at a subset of distal spines that are much smaller than proximal spines. Additionally, we found that the amount of blockade with ifenprodil was unrelated to synapse position. Overall, we conclude that despite a slight correlation between synapse position and mSCaT amplitude, synapse position is not a primary modulator of NMDAR-mediated Ca^2+^ influx between synapses.

Major remaining options for the source of variability in NMDAR activation are phosphorylation state of NMDARs, presynaptic changes in the amount of glutamate released between events, or finally, random variation in channel open time. Phosphorylation of the NMDAR can modify channel conductance and lead to changes in Ca^2+^ influx ([@B110]; [@B83]; [@B94]; [@B16]). These changes can occur on the timescale of minutes ([@B110]), which although not completely incompatible with our average mSCaT frequency of ∼2 events per minute, is unlikely to have contributed substantially to within-synapse variance in our experiments. However, it has been shown that preventing receptor phosphorylation alters basal transmission ([@B110]; [@B94]), which suggests that there is some basal level of NMDAR phosphorylation ongoing that can modify NMDAR properties. Thus, although it is unclear whether NMDAR receptor phosphorylation would be sufficient to mediate the large amount of variability observed within synapses, it appears able to play a role in distinguishing NMDAR-mediated Ca^2+^ influx between synapses.

Differences in the amount of glutamate release per event have long been thought to be a major contributor to variability in the amount of receptor activation by spontaneous release ([@B11]; [@B58]; [@B66]; [@B38]; [@B31]). Modeling the amount of AMPAR activation with varying quantal size has demonstrated an increase in the number of activated receptors as glutamate molecules per vesicle is increased ([@B31]). Despite the likely small number of NMDARs activated per event ([@B70]), it is possible that there is variability in the number of NMDARs activated that is in part because of differences in the amount of glutamate released at each event. In addition to the amount of glutamate per vesicle, the release site position with respect to receptor position could also underlie variability in the amount of receptor activation. Modeling receptor activation due to glutamate release at different distances from the highest density of receptors has suggested that release site position could play a large role in the variability in response amplitude ([@B108]; [@B60]; [@B88]). Especially in the case of spontaneous release which may occur more randomly across the active zone than evoked release ([@B105]), release position may play a role in inter-event variability. Finally, another likely source of variability in Ca^2+^ influx per event is stochastic channel open-close transitions ([@B31]). GluN2B-NMDARs have a relatively low open probability ([@B19]), which could produce large essentially random changes in the amount of Ca^2+^ influx per event ([@B116]; [@B117]). Especially in this case where there are very few NMDARs activated per event, these random fluctuations could dominate the variability.

Overall, we conclude that the high degree of variability in the amount of Ca^2+^ influx through spontaneous activated NMDARs is not primarily because of synapse-specific features including the number of available receptors, NMDAR subtype, synapse size, or synapse position within the dendritic tree. Rather, the high degree of variability of spontaneous NMDAR activation is most likely dominated by nanoscale intrinsic properties of the synapse that influence receptor activation probability, including receptor position, release site position, and the glutamate concentration profile following each release event, and by the highly varying open time of the channels that do become activated.

Synthesis {#s6}
=========

Reviewing Editor: Pablo Castillo, Albert Einstein College of Medicine

Decisions are customarily a result of the Reviewing Editor and the peer reviewers coming together and discussing their recommendations until a consensus is reached. When revisions are invited, a fact-based synthesis statement explaining their decision and outlining what is needed to prepare a revision will be listed below. The following reviewer(s) agreed to reveal their identity: John Gray.

Your manuscript has been evaluated by two experts in the field. They both appreciate the quality of the results and potential relevance of your study. However, they raise a number of concerns regarding the analysis and interpretation of your findings. The reviewers fully agree in that additional experiments are required to strengthen the main conclusions of your paper. Below please find the reviewers\' specific comments.

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

Reviewer \#1

In the present manuscript, the authors have utilized a previously published calcium-imaging-based approach to examine the NMDA receptor populations activated by spontaneous neurotransmission in cultured neurons. The authors describe the population of NMDARs activated during spontaneous events to be largely GluN2B-containing. Further, the amplitude of the calcium transients was highly variable, but independent of spine/PSD size, but weakly positively correlated with distance from the soma. This is a timely and important topic given the accumulating evidence for (1) separate pools of vesicles for spontaneous vs evoked release; (2) trans-synaptically aligned nanocolumns; (3) different pools (or nanodomains) of postsynaptic receptors; and (4) the potential importance of spontaneous release in the rapid antidepressant effects of ketamine. The experiments seem rigorously and carefully executed and the text is well written. I particularly enjoyed reading the thoughtful discussion. The Results section and Figure Legends, however, could use additional clarity and actual Figures could be better labeled. As described below there are a number of issues:

Major Concerns:

1\. This study would be significantly improved if the authors correlated the mSCaT data with evoked SCaTs (e.g. in Reese and Kavalali, eLife 2016). For example, evoked SCaTs may have a high percentage of GluN2A-containing receptors compared to the mSCaTs - especially interesting if at the same synapses.

2\. Since this study is performed in cultured neurons, there should be confirmation that there is significant synaptic GluN2A at this DIV. This is especially important since GCaMP6f was expressed for 21 DIVs and the buffering of Ca2+ by GCaMP (McMahon and Jackson, Trends in Neurosci 2018) may be impairing the switch from GluN2B to GluN2A similar to BAPTA (Bellone and Nicoll, Neuron 2007). If this is happening, then of course you would only see GluN2B and the conclusions of the study would be flawed. (Indeed, the authors mentioned a "striking lack of GluN2A" on line 429).

3\. Some description or measurement of the number of spines that do not show spontaneous calcium transients is warranted. Is there a selection bias? How are the recorded/imaged synapses selected? How many spines are quiescent?

4\. 6uM ifenprodil was chosen from a study using mutant forced-triheteromeric receptors. Slice physiology with pure populations of GluN2A and GluN2B receptors have suggested that 3uM is the upper limit of selectivity. Thus, confirmation with Ro25 and/or a "selective" 2A inhibitor (e.g. TCN201) would strengthen the arguments.

5\. Figure 4: The conclusion that distance from soma is correlated with mSCaT size seems weak based on the raw data in 4D with an effect only showing up robustly in the binned data. One concern is that the data only extends to \~150 um of the soma which is quite short relative to the dendritic lengths of pyramidal neurons. Extension of these data to \~300um would be useful for this correlation (I suspect this would require sparse transfection). Also, what are the bins and how were they chosen?

6\. Is "branch depth" physiologically meaningful? Perhaps "branch order" would be more meaningful. The primary apical dendrite being 1st order. Then compare with 2nd and 3rd order dendrites. Indeed, distal branches/tufts of many pyramidal cells follow different rules (e.g. distance-dependent scaling of mEPSC amplitudes) and thus there may be differential calcium responses to spontaneous release.

Minor Concerns:

1\. Abstract: "It is most likely that NMDAR activation by spontaneous release influenced variability in subsynaptic receptor position, release position, vesicle content, and channel properties" - this is entirely speculative, so "it is most likely" is too strong. I\'m not sure this sentence belongs in the abstract at all, but at the minimum needs to be edited to indicate these are the other possibilities that were not formally examined in the current study. This is again mentioned in the Introduction and Discussion ("most likely").

2\. Methods: The zero or low Mg2+ used in the experiments should be explicitly mentioned here and throughout the manuscript.

3\. Methods: please include a description of how data were binned, for example in Fig 3C. This was described at attempting to avoid "overpowering" the analysis - were there calculations of how the original data could be overpowered? And, if the binning resulted in appropriate power?

4\. Results: Lines 255-259 - it is unclear to me if you are referring to intra-spine CV or inter-spine CV. Also unclear if this is represented in the Figures, perhaps Fig 1G/H but it is just unclear to me.

5\. Figure 2C - what do the box and whiskers plots actually represent? Not mentioned in figure legend or methods. Are there outliers outside the whiskers? Perhaps violin plots would be better or a scatter plot of all points.

6\. Figure 2E/F - include the R\^2 value in the graph as in the other figures.

7\. Figure 2G/H - in the text of the Results, the authors discuss the "weak negative correlation" in 2G and 2H, please add the regression and analysis of these correlations.

8\. The labels of graph axes could be more informative by just looking at the figure. For example, in Figure 2G, the "Norm. mSCaT amp." is actually post-ifenprodil. There are numerous examples throughout the manuscript where figure labeling could be clearer.

9\. Line 304 - "entirely GluN2B\...mediated" is too strong

10\. Lines 347-348 - need to add "for spontaneous release events" in here somewhere.

11\. Line 489-490: The variability on GluN2B open time (and thus decay) is largely mediated by the GluN2B NTD. Allosteric modulators of this NTD (e.g. ifenprodil) reduce much of this variability. So the interpretation here could be just a direct effect on 2B.

12\. I liked the discussion of possible non-ionotropic signaling roles, given that spontaneous neurotransmission is unlikely to induce a level of postsynaptic depolarization sufficient for relief of the Mg2+ block.

Reviewer \#2

In this manuscript, the authors examine factors that regulate the magnitude of NMDAR activation by spontaneous neurotransmitter release at single synapses. Using GCamP6 to measure spine calcium transients, they report that the amplitude of calcium transients varies widely both between synapses and at individual synapses. This variability is reduced following inhibition of NR2B subunits, which they show carry the majority of Ca2+ currents at these synapses. They report that the variability is not correlated with spine or synapse size and only weakly correlated with distance from the soma.

Although several prior studies identified sources of variability for NMDAR-mediated calcium transients in single synapses in response to synaptic stimulation or glutamate uncaging, and following plasticity protocols, this study focuses on spontaneous neurotransmitter release, which has recently been in the spotlight as potentially playing an important functional role and operating at distinct release sites. Thus, the study examines an important and significant question. However, several points require attention.

Specific Points:

1\. After concluding that spine and synapse size and distance from the soma are not the major sources responsible for the variability in calcium transient amplitude they observed at single synapses, the authors discuss several alternative possible sources, including receptor positioning, vesicle content and channel properties. A few additional alternatives might be worth considering. In addition to spine volume, calcium transient amplitude will be governed by spine neck geometry, calcium buffering and extrusion, although these have been shown to be relatively stable at single synapses. Another factor worth considering would be availability of the requisite co-agonist. Earlier studies at single synapses included d-Serine in the bath to saturate the co-agonist site.

2\. The authors claim in the abstract and in several places in the text that they "found that NMDARs activated by spontaneous release tend to be GluN2B-NMDARs". However, calcium can contribute \~10% of the current through NMDARs and different subunits contribute different proportional amounts of calcium, therefore, it is difficult to assess NMDAR activation solely by measuring calcium transients. In the absence of electrophysiological recordings, it would be more accurate to restrict this conclusion to stating that the GluN2B subunit is carrying the majority of the calcium current in response to spontaneous release at single synapses.

3\. Considering the volume of prior data demonstrating that NMDAR content is not correlated or only weakly correlated with spine size, and that NMDAR-mediated calcium transients are also uncorrelated with the current amplitudes, it may be worthwhile to eliminate the word surprising from "Surprisingly, the amount of receptor activation is independent of the size of the synapse" because while interesting and worth reporting for spontaneous release, it is perhaps not surprising.

4\. Measuring spine size using a calcium-sensitive fluorescent probe is likely to be inaccurate, as volume measurements will be confounded by levels of baseline calcium signals at individual spines - a dye fill is the standard approach. In addition, spine volume changes over time will influence calcium transient amplitude, thus it is preferable to normalize calcium transients to a dye fill to eliminate this variability. Finally, the non-linearity of GCamP6f could be a source of variability - it is not clear why one of the organic dyes were not chosen for these experiments.

5\. In Figure 1, it is not clear what the trace labeled "spine region" refers to - is this the single large spine in that region - if so, please label the spine and the trace accordingly. If not, single spine traces should be provided so that variability can be examined. Example traces should be provided for each of the conditions listed in Figure 1, including 'Blockers', 'APV', '1 mM Mg2+', etc. Furthermore, please examine closely the Figure 1 legend - it appears to be mislabeled relative to the Figure panels.

6\. The text describes Figure 1 calcium levels as 1.5 mM and 1.88 mM to demonstrate the absence of saturation. However, the methods specify 2 mM. This should be clarified in the text.

7\. Please provide a cumulative plot in Figure 2C (as in Figure 2D).
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